JO
BIOA

John Overdeck’s BioAge Labs BIOA Stock Holding History

John Overdeck’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
61,394
+14,443
+31% +$261K ﹤0.01% 3262
2026
Q1 		$821K Buy
46,951
+4,800
+11% +$92.4K ﹤0.01% 3408
2025
Q4 		$558K Sell
42,151
-57,518
-58% -$510K ﹤0.01% 3245
2025
Q3 		$586K Buy
99,669
+35,068
+54% +$164K ﹤0.01% 2909
2025
Q2 		$267K Buy
64,601
+49,456
+327% +$199K ﹤0.01% 2832
2025
Q1 		$56.9K Buy
+15,145
New +$70K ﹤0.01% 3030
2024
Q4 		– Sell
-11,500
Closed -$239K – 3534
2024
Q3 		$239K Buy
+11,500
New +$230K ﹤0.01% 2753

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

John Overdeck's BIOA Position: Q2 2026 in Review

John Overdeck increased its BioAge Labs (BIOA) stake by 31% in Q2 2026, buying an estimated $261K and bringing the position to 61,394 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3262.

John Overdeck first reported a position in BIOA in Q3 2024 and has held it in 7 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • John Overdeck held 61,394 shares of BioAge Labs worth $1.5M as of Q2 2026.
  • John Overdeck bought 14,443 BioAge Labs shares in Q2 2026, an estimated $261K.
  • BioAge Labs made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3262 holding.
  • John Overdeck first reported a position in BioAge Labs in Q3 2024 and has held it in 7 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.